Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2006;82:95-100; doi:10.1136/pgmj.2005.036137
Copyright © 2006 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bansal, V
Right arrow Articles by Misra, U K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bansal, V
Right arrow Articles by Misra, U K

REVIEW

Diabetic neuropathy

V Bansal , J Kalita , U K Misra

Department of Neurology, Sanjay Gandhi PGIMS, Lucknow, India

Correspondence to:
Correspondence to:
Professor U K Misra
Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareilly Road, Lucknow 226014, India; ukmisra{at}sgpgi.ac.in

Diabetic neuropathy (DN) refers to symptoms and signs of neuropathy in a patient with diabetes in whom other causes of neuropathy have been excluded. Distal symmetrical neuropathy is the commonest accounting for 75% DN. Asymmetrical neuropathies may involve cranial nerves, thoracic or limb nerves; are of acute onset resulting from ischaemic infarction of vasa nervosa. Asymmetric neuropathies in diabetic patients should be investigated for entrapment neuropathy. Diabetic amyotrophy, initially considered to result from metabolic changes, and later ischaemia, is now attributed to immunological changes. For diagnosis of DN, symptoms, signs, quantitative sensory testing, nerve conduction study, and autonomic testing are used; and two of these five are recommended for clinical diagnosis. Management of DN includes control of hyperglycaemia, other cardiovascular risk factors; {alpha} lipoic acid and L carnitine. For neuropathic pain, analgesics, non-steroidal anti-inflammatory drugs, antidepressants, and anticonvulsants are recommended. The treatment of autonomic neuropathy is symptomatic.


Abbreviations: DN, diabetic neuropathy; DM, diabetes mellitus; DSPN, distal symmetrical polyneuropathy; NCV, nerve conduction velocity; ARI, aldolase reductase inhibitor; ALC, acetyl L carnitine; NGF, nerve growth factor; CIDP, chronic inflammatory demyelinating neuropathy

Keywords: neuropathy; diabetes; treatment; classification; pathophysiology




This article has been cited by other articles:


Home page
CJASNHome page
C. Leon and A. Asif
Arteriovenous Access and Hand Pain: The Distal Hypoperfusion Ischemic Syndrome
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 175 - 183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 The Fellowship of Postgraduate Medicine